1. Home
  2. ITOS vs WSBF Comparison

ITOS vs WSBF Comparison

Compare ITOS & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • WSBF
  • Stock Information
  • Founded
  • ITOS 2011
  • WSBF 1921
  • Country
  • ITOS United States
  • WSBF United States
  • Employees
  • ITOS N/A
  • WSBF N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • WSBF Savings Institutions
  • Sector
  • ITOS Health Care
  • WSBF Finance
  • Exchange
  • ITOS Nasdaq
  • WSBF Nasdaq
  • Market Cap
  • ITOS 272.5M
  • WSBF 269.9M
  • IPO Year
  • ITOS 2020
  • WSBF N/A
  • Fundamental
  • Price
  • ITOS $7.48
  • WSBF $13.71
  • Analyst Decision
  • ITOS Strong Buy
  • WSBF
  • Analyst Count
  • ITOS 3
  • WSBF 0
  • Target Price
  • ITOS $21.33
  • WSBF N/A
  • AVG Volume (30 Days)
  • ITOS 268.0K
  • WSBF 54.4K
  • Earning Date
  • ITOS 03-05-2025
  • WSBF 01-28-2025
  • Dividend Yield
  • ITOS N/A
  • WSBF 4.38%
  • EPS Growth
  • ITOS N/A
  • WSBF 118.94
  • EPS
  • ITOS N/A
  • WSBF 1.01
  • Revenue
  • ITOS $35,000,000.00
  • WSBF $135,638,000.00
  • Revenue This Year
  • ITOS $271.18
  • WSBF N/A
  • Revenue Next Year
  • ITOS N/A
  • WSBF N/A
  • P/E Ratio
  • ITOS N/A
  • WSBF $13.38
  • Revenue Growth
  • ITOS N/A
  • WSBF 3.74
  • 52 Week Low
  • ITOS $7.09
  • WSBF $10.60
  • 52 Week High
  • ITOS $18.75
  • WSBF $16.86
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 43.24
  • WSBF 49.42
  • Support Level
  • ITOS $7.30
  • WSBF $13.37
  • Resistance Level
  • ITOS $7.91
  • WSBF $13.63
  • Average True Range (ATR)
  • ITOS 0.32
  • WSBF 0.38
  • MACD
  • ITOS -0.02
  • WSBF 0.14
  • Stochastic Oscillator
  • ITOS 17.82
  • WSBF 55.50

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.

Share on Social Networks: